Publications by authors named "Claus M Escher"
Alzheimer's disease (AD) is the leading cause of dementia worldwide. Due to demographic change in higher income countries and rising life expectancy in middle- and low-income countries, the prevalence of AD will increase significantly in the coming years. In the search for effective AD prevention, the role of stress in the development of AD has come into focus.
View Article and Find Full Text PDFBotulinum toxin in the management of chronic migraine: clinical evidence and experience.
Ther Adv Neurol Disord
February 2017
Article Synopsis
- * The FDA approved onabotulinumtoxinA (Botox) in 2010 for preventing CM, and it has been shown to reduce both the frequency and intensity of headaches.
- * The review covers the history and current clinical evidence supporting the use of onabotulinumtoxinA in managing chronic migraines.
Botulinum toxin was shown to be effective in treatment of chronic migraine. We wanted to explore its efficacy and tolerability in chronic application under real-life conditions. For this, 27 consecutive patients (age 45.
View Article and Find Full Text PDF